Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Nafamostat Efficacy and Safety in Critically Ill Patients(NICE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2013 by Seoul National University Hospital
Sponsor:
Collaborator:
SK Chemicals Co.,Ltd.
Information provided by (Responsible Party):
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01486485
First received: December 2, 2011
Last updated: February 18, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)